Paeds Vivas · genetics-dysmorphology-and-metabolism
Dysmorphology examination — branching viva
Viva on structured dysmorphology examination, anomaly classification, syndrome differential and tiered genetic testing.
On this page & tools
Target exams
Opening stem
You are the paediatric registrar in clinical genetics clinic. A 6-month-old is referred for an unusual face and developmental delay. Talk me through your assessment. [1]
Branch A — Candidate opens with structured examination
Examiner: Good. How do you describe the findings, and why does the vocabulary matter? [1]
Strong answer: Observe the settled, undressed child first, then examine head to toe, describing each feature in standard Elements of morphology terms and measuring against norms. Standard terminology makes findings reproducible between clinicians and over time, and avoids vague labels. I photograph with consent and examine the parents. [1]
Branch B — Classification of anomalies
Examiner: How do you classify what you find? [3]
Strong answer: Two axes — mechanism (malformation, disruption, deformation, dysplasia, with an example of each) and significance (major versus minor). A cluster of three or more minor anomalies substantially raises the probability of a syndrome and prompts a structured search. [3] [5]
Branch C — Generating the differential
Examiner: How do you narrow the differential from here? [5]
Strong answer: Group the truly abnormal findings (using measurements and parental examination to strip out familial or ethnic variants) into a pattern, then compare against databases (London Dysmorphology Database, OMIM, Human Phenotype Ontology) and a deep-learning facial-analysis tool as support. A tool match never replaces clinical judgement or genetic confirmation. [5] [12]
Branch D — First-tier testing
Examiner: What is your first genetic test, and why? [9]
Strong answer: Chromosomal microarray is first-tier for unexplained developmental delay and multiple congenital anomalies because it detects submicroscopic copy-number changes a karyotype misses, with a yield of roughly 10 to 15 percent; a karyotype is reserved for a suspected balanced rearrangement. [9]
Branch E — Negative microarray
Examiner: The microarray is negative and you still suspect a monogenic syndrome. Now what? [10]
Strong answer: Escalate to exome or genome sequencing, which adds a substantial diagnostic increment; I also organise the organ-targeted work-up the pattern demands and arrange genetic counselling and a clear review point for the family. [7] [10]
Closing marks map
- Structured, terminology-driven examination with measurements and parental examination. [1]
- Correct two-axis classification and the three-or-more-minor-anomalies rule. [3] [5]
- CMA as first-tier, then exome or genome, with honest counselling and a safety-net review. [9] [10]
References
- [1]Allanson JE, Biesecker LG, Carey JC, Hennekam RC Elements of morphology: introduction. American Journal of Medical Genetics Part A, 2009.PMID 19127575
- [3]Hennekam RC, Biesecker LG, Allanson JE, Hall JG, Opitz JM, Temple IK Elements of morphology: general terms for congenital anomalies. American Journal of Medical Genetics Part A, 2013.PMID 24124000
- [5]Carey JC, Allanson JE, Hennekam RC, Biesecker LG Standard terminology for phenotypic variations: the elements of morphology project, its current progress, and future directions. Human Mutation, 2012.PMID 22331827
- [7]Moeschler JB, Shevell M, American Academy of Pediatrics Committee on Genetics Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics, 2006.PMID 16740881
- [9]Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 2010.PMID 20466091
- [10]Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 2021.PMID 34211152
- [12]Gurovich Y, Hanani Y, Bar O, Nadav G, Fleischer N, Gelbman D Identifying facial phenotypes of genetic disorders using deep learning. Nature Medicine, 2019.PMID 30617323